In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-14 of 14 for your search:
Drug:  mivobulin isethionate
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-NCNSC-95003, NCI-T95-0101O, T95-0101

2.

Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NABTT-9602, JHOC-NABTT-9602, NCI-T96-0027H

3.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-95217, NCI-T95-0102H, T95-0102

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: adult
Sponsor: NCI
Protocol IDs: SWOG-S9622, SWOG-9622, S9622

5.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8182, NCI-T96-0008H, T96-0008

6.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8183, NCI-T96-0007H, T96-0007

7.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8254, NCI-T96-0048H, T96-0048

8.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: OSU-9614, OSU-T96-9614, NCI-T96-0020H, T96-0020

9.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UCCRC-8184, NCI-T96-0006H, T96-0006

10.

Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-T93-0186, NCI-T93-0186D, T93-0186

11.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: UMCC-9316, NCI-T93-0194O, T93-0194

12.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9470

13.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 21 and under
Sponsor: NCI
Protocol IDs: POG-9472

14.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 80
Sponsor:
Protocol IDs: AECM-9008246, NCI-V92-0009
New Search